Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LANCELOT: Insulin Glargine vs NPH in T2DM
NCT00949442Phase 4Completed
- Sponsor
- Sanofi
- Start
- Jul 2009
- Primary completion
- Jul 2012
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 17
01
Overview
A Phase 4 trial of insulin glargine in type 2 diabetes mellitus (T2DM), sponsored by Sanofi. Started Jul 2009; status: completed.
02
Drugs
insulin glargine
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00949442.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00949442.